NASDAQ:CYCC - Cyclacel Pharmaceuticals News Headlines

Sign in or create an account to add this stock to your watchlist.
$0.76 +0.14 (+22.47 %)
(As of 05/27/2019 06:00 AM ET)
Previous Close$0.7630
Today's Range$0.7050 - $1.02
52-Week Range$0.51 - $1.87
Volume27.92 million shs
Average Volume785,588 shs
Market Capitalization$13.12 million
P/E RatioN/A
Dividend YieldN/A
Beta3.36

Headlines

Cyclacel Pharmaceuticals (NASDAQ CYCC) News Headlines

Source:
DateHeadline
Cyclacel Pharmaceuticals Inc.Cyclacel Pharmaceuticals Inc.
www.barrons.com - May 24 at 6:38 PM
HC Wainwright Reiterates Buy Rating for Cyclacel Pharmaceuticals (CYCC)HC Wainwright Reiterates Buy Rating for Cyclacel Pharmaceuticals (CYCC)
www.americanbankingnews.com - May 16 at 7:07 AM
Edited Transcript of CYCC earnings conference call or presentation 14-May-19 8:30pm GMTEdited Transcript of CYCC earnings conference call or presentation 14-May-19 8:30pm GMT
finance.yahoo.com - May 15 at 8:54 AM
Cyclacel Pharmaceuticals, Inc. (CYCC) CEO Spiro Rombotis on Q1 2019 Results - Earnings Call TranscriptCyclacel Pharmaceuticals, Inc. (CYCC) CEO Spiro Rombotis on Q1 2019 Results - Earnings Call Transcript
seekingalpha.com - May 14 at 7:41 PM
Brokerages Expect Cyclacel Pharmaceuticals Inc (CYCC) to Post ($0.19) EPSBrokerages Expect Cyclacel Pharmaceuticals Inc (CYCC) to Post ($0.19) EPS
www.americanbankingnews.com - May 13 at 10:14 PM
 Brokerages Anticipate Cyclacel Pharmaceuticals Inc (CYCC) to Post -$0.19 Earnings Per Share Brokerages Anticipate Cyclacel Pharmaceuticals Inc (CYCC) to Post -$0.19 Earnings Per Share
www.americanbankingnews.com - May 9 at 12:40 PM
Cyclacel Pharmaceuticals (CYCC) to Release Earnings on TuesdayCyclacel Pharmaceuticals (CYCC) to Release Earnings on Tuesday
www.americanbankingnews.com - May 9 at 10:21 AM
Cyclacel Pharmaceuticals to Release First Quarter 2019 Financial ResultsCyclacel Pharmaceuticals to Release First Quarter 2019 Financial Results
finance.yahoo.com - May 8 at 8:47 AM
Could Cyclacel Pharmaceuticals, Inc.'s (NASDAQ:CYCC) Investor Composition Influence The Stock Price?Could Cyclacel Pharmaceuticals, Inc.'s (NASDAQ:CYCC) Investor Composition Influence The Stock Price?
finance.yahoo.com - April 29 at 6:25 PM
Cash Dividend On The Way From Cyclacel Pharmaceuticals Convertible Exchangeable Preferred StockCash Dividend On The Way From Cyclacel Pharmaceuticals Convertible Exchangeable Preferred Stock
www.nasdaq.com - April 10 at 7:58 PM
Cyclacel down 4% on sapacitabine/seliciclib dataCyclacel down 4% on sapacitabine/seliciclib data
seekingalpha.com - April 1 at 7:34 PM
Cyclacel Announces Presentation of Phase 1 Data of Sapacitabine Regimen in Patients With BRCA Mutant Breast Cancer at AACR 2019Cyclacel Announces Presentation of Phase 1 Data of Sapacitabine Regimen in Patients With BRCA Mutant Breast Cancer at AACR 2019
finance.yahoo.com - April 1 at 8:55 AM
Cyclacel Pharmaceuticals, Inc. (CYCC) CEO Spiro Rombotis on Q4 2018 Results - Earnings Call TranscriptCyclacel Pharmaceuticals, Inc. (CYCC) CEO Spiro Rombotis on Q4 2018 Results - Earnings Call Transcript
seekingalpha.com - March 28 at 9:00 AM
Edited Transcript of CYCC earnings conference call or presentation 27-Mar-19 8:30pm GMTEdited Transcript of CYCC earnings conference call or presentation 27-Mar-19 8:30pm GMT
finance.yahoo.com - March 28 at 9:00 AM
CYCLACEL PHARMACEUTICALS, INC. CYCC Files An 8-K Results of Operations and Financial ConditionCYCLACEL PHARMACEUTICALS, INC. CYCC Files An 8-K Results of Operations and Financial Condition
www.marketwatch.com - March 27 at 7:19 PM
Journal of Clinical OncologyJournal of Clinical Oncology
www.benzinga.com - March 27 at 8:55 AM
Cyclacel Drops After Study Supporting Cancer Drugs Mechanism Of ActionCyclacel Drops After Study Supporting Cancer Drug's Mechanism Of Action
feeds.benzinga.com - March 26 at 1:36 PM
Cyclacel Provides Clinical Development Update and Growth Drivers for 2019 in New SNNLive Video Interview on StockNewsNow.comCyclacel Provides Clinical Development Update and Growth Drivers for 2019 in New SNNLive Video Interview on StockNewsNow.com
finance.yahoo.com - March 26 at 8:57 AM
Cyclacel Pharmaceuticals, Inc. Estimate MomentumCyclacel Pharmaceuticals, Inc. Estimate Momentum
www.nasdaq.com - March 18 at 7:28 PM
Cyclacel Announces Abstracts Selected for Presentation at the American Association for Cancer Research Annual Meeting 2019Cyclacel Announces Abstracts Selected for Presentation at the American Association for Cancer Research Annual Meeting 2019
www.marketwatch.com - March 5 at 9:05 AM
Cyclacel Announces Abstracts Selected for Presentation at the American Association for Cancer Research Annual Meeting 2019Cyclacel Announces Abstracts Selected for Presentation at the American Association for Cancer Research Annual Meeting 2019
finance.yahoo.com - March 5 at 9:05 AM
Cyclacel Pharmaceuticals to Present at Biotech Showcase(TM) 2019 in San FranciscoCyclacel Pharmaceuticals to Present at Biotech Showcase(TM) 2019 in San Francisco
www.marketwatch.com - January 21 at 5:40 PM
Cyclacel Pharmaceuticals Reviews 2018 Achievements and Announces Key Business Objectives for 2019Cyclacel Pharmaceuticals Reviews 2018 Achievements and Announces Key Business Objectives for 2019
finance.yahoo.com - January 7 at 8:35 AM
Cyclacel Pharmaceuticals to Present at Biotech Showcase™ 2019 in San FranciscoCyclacel Pharmaceuticals to Present at Biotech Showcase™ 2019 in San Francisco
finance.yahoo.com - December 27 at 8:55 AM
Does Cyclacel Pharmaceuticals, Inc.’s (NASDAQ:CYCC) CEO Pay Reflect Performance?Does Cyclacel Pharmaceuticals, Inc.’s (NASDAQ:CYCC) CEO Pay Reflect Performance?
finance.yahoo.com - December 25 at 4:59 PM
The Daily Biotech Pulse: Legal Victory For Boston Scientific, Alder Gets New CFO, FDA Go-Ahead For BioXcelThe Daily Biotech Pulse: Legal Victory For Boston Scientific, Alder Gets New CFO, FDA Go-Ahead For BioXcel
www.msn.com - December 12 at 8:45 AM
Cyclacel Pharmaceuticals, Inc. (CYCC) CEO Spiro Rombotis on Q3 2018 Results - Earnings Call TranscriptCyclacel Pharmaceuticals, Inc. (CYCC) CEO Spiro Rombotis on Q3 2018 Results - Earnings Call Transcript
seekingalpha.com - November 13 at 8:31 AM
Edited Transcript of CYCC earnings conference call or presentation 12-Nov-18 9:30pm GMTEdited Transcript of CYCC earnings conference call or presentation 12-Nov-18 9:30pm GMT
finance.yahoo.com - November 13 at 8:31 AM
Cyclacel Pharmaceuticals to Release Third Quarter 2018 Financial ResultsCyclacel Pharmaceuticals to Release Third Quarter 2018 Financial Results
finance.yahoo.com - November 6 at 8:41 AM
Cyclacel Pharmaceuticals (CYCC) Presents At DAWSON JAMES 4th Annual Small Cap Growth Conference - SlideshowCyclacel Pharmaceuticals (CYCC) Presents At DAWSON JAMES 4th Annual Small Cap Growth Conference - Slideshow
seekingalpha.com - November 1 at 8:29 AM
Report: Exploring Fundamental Drivers Behind Invitae, Aerie Pharmaceuticals, Gevo, Global Medical REIT, Cyclacel Pharmaceuticals, and Toll Brothers — New Horizons, Emerging Trends, and Upcoming DevelopmentsReport: Exploring Fundamental Drivers Behind Invitae, Aerie Pharmaceuticals, Gevo, Global Medical REIT, Cyclacel Pharmaceuticals, and Toll Brothers — New Horizons, Emerging Trends, and Upcoming Developments
finance.yahoo.com - October 25 at 8:44 AM
Cyclacel Pharmaceuticals to Present at the Dawson James Small Cap Growth ConferenceCyclacel Pharmaceuticals to Present at the Dawson James Small Cap Growth Conference
finance.yahoo.com - October 23 at 8:37 AM
Cyclacel Pharmaceuticals collaborates with MD Anderson Cancer Center to study medicines in hematological malignancies; shares ahead 18% premarketCyclacel Pharmaceuticals collaborates with MD Anderson Cancer Center to study medicines in hematological malignancies; shares ahead 18% premarket
seekingalpha.com - October 4 at 8:31 AM
Cyclacel Pharmaceuticals and MD Anderson Cancer Center Announce Strategic Alliance to Study Novel Cyclacel Medicines in Hematological MalignanciesCyclacel Pharmaceuticals and MD Anderson Cancer Center Announce Strategic Alliance to Study Novel Cyclacel Medicines in Hematological Malignancies
finance.yahoo.com - October 4 at 8:31 AM
Cyclacel Pharmaceuticals to Present at the Ladenburg Thalmann 2018 Healthcare ConferenceCyclacel Pharmaceuticals to Present at the Ladenburg Thalmann 2018 Healthcare Conference
finance.yahoo.com - September 26 at 8:51 AM
What does Cyclacel Pharmaceuticals Inc’s (NASDAQ:CYCC) Balance Sheet Tell Us About Its Future?What does Cyclacel Pharmaceuticals Inc’s (NASDAQ:CYCC) Balance Sheet Tell Us About Its Future?
finance.yahoo.com - September 20 at 4:43 PM
Cyclacel Pharmaceuticals Appoints Robert J. Spiegel, M.D. to Board of DirectorsCyclacel Pharmaceuticals Appoints Robert J. Spiegel, M.D. to Board of Directors
finance.yahoo.com - September 12 at 8:37 AM
Cyclacel Pharmaceuticals initiates Phase 1b/2 trial of sapacitabine with olaparib in BRCA mutant breast cancerCyclacel Pharmaceuticals initiates Phase 1b/2 trial of sapacitabine with olaparib in BRCA mutant breast cancer
seekingalpha.com - September 10 at 8:47 AM
Cyclacel Pharmaceuticals Announces Initiation of Phase 1b/2 Clinical Trial of Sapacitabine With Olaparib in BRCA Mutant Breast CancerCyclacel Pharmaceuticals Announces Initiation of Phase 1b/2 Clinical Trial of Sapacitabine With Olaparib in BRCA Mutant Breast Cancer
finance.yahoo.com - September 10 at 8:47 AM
Cyclacel Pharmaceuticals to Present at the 20th Annual H.C. Wainwright Global Investment ConferenceCyclacel Pharmaceuticals to Present at the 20th Annual H.C. Wainwright Global Investment Conference
finance.yahoo.com - August 29 at 8:55 AM
Edited Transcript of CYCC earnings conference call or presentation 9-Aug-18 8:30pm GMTEdited Transcript of CYCC earnings conference call or presentation 9-Aug-18 8:30pm GMT
finance.yahoo.com - August 23 at 4:52 PM
Investor Expectations to Drive Momentum within Global Medical REIT, Cyclacel Pharmaceuticals, Super Micro Computer, Kelly Services, Invitae, and ScanSource — Discovering Underlying Factors of InfluenceInvestor Expectations to Drive Momentum within Global Medical REIT, Cyclacel Pharmaceuticals, Super Micro Computer, Kelly Services, Invitae, and ScanSource — Discovering Underlying Factors of Influence
finance.yahoo.com - August 16 at 8:45 AM
Cyclacel Pharmaceuticals, Inc. (CYCC) CEO Spiro Rombotis on Q2 2018 Results - Earnings Call TranscriptCyclacel Pharmaceuticals, Inc. (CYCC) CEO Spiro Rombotis on Q2 2018 Results - Earnings Call Transcript
seekingalpha.com - August 10 at 8:42 AM
Cyclacel Pharmaceuticals Reports Second Quarter 2018 Financial ResultsCyclacel Pharmaceuticals Reports Second Quarter 2018 Financial Results
finance.yahoo.com - August 9 at 5:29 PM
Cyclacel Pharmaceuticals to Release Second Quarter 2018 Financial ResultsCyclacel Pharmaceuticals to Release Second Quarter 2018 Financial Results
finance.yahoo.com - August 1 at 9:30 AM
Who Really Owns Cyclacel Pharmaceuticals Inc (NASDAQ:CYCC)?Who Really Owns Cyclacel Pharmaceuticals Inc (NASDAQ:CYCC)?
finance.yahoo.com - May 25 at 5:22 PM
Edited Transcript of CYCC earnings conference call or presentation 14-May-18 8:30pm GMTEdited Transcript of CYCC earnings conference call or presentation 14-May-18 8:30pm GMT
finance.yahoo.com - May 21 at 8:38 AM
Cyclacel Pharmaceuticals (CYCC) CEO Spiro Rombotis on Q1 2018 Results - Earnings Call TranscriptCyclacel Pharmaceuticals' (CYCC) CEO Spiro Rombotis on Q1 2018 Results - Earnings Call Transcript
seekingalpha.com - May 15 at 9:01 AM
Cyclacel Pharmaceuticals Reports First Quarter 2018 Financial ResultsCyclacel Pharmaceuticals Reports First Quarter 2018 Financial Results
finance.yahoo.com - May 14 at 5:03 PM
Cyclacel Announces Presentation of Phase 1 Clinical Data for CDK Inhibitor CYC065 at AACR 2018 Annual MeetingCyclacel Announces Presentation of Phase 1 Clinical Data for CDK Inhibitor CYC065 at AACR 2018 Annual Meeting
feeds.benzinga.com - April 16 at 7:46 AM
This page was last updated on 5/27/2019 by MarketBeat.com Staff

Enter your email address below to receive a concise daily summary of analysts' upgrades, downgrades and new coverage with MarketBeat.com's FREE daily email newsletter.

Yahoo Gemini Pixel